DK154221C - Tripeptidderivater og fremgangsmaade til kvantitativt at analysere faktor xa i et xa-holdigt medium, faktor x i blodplasma, heparin i hepariniseret blodplasma eller antifaktor xa i blodplasma - Google Patents

Tripeptidderivater og fremgangsmaade til kvantitativt at analysere faktor xa i et xa-holdigt medium, faktor x i blodplasma, heparin i hepariniseret blodplasma eller antifaktor xa i blodplasma

Info

Publication number
DK154221C
DK154221C DK451981A DK451981A DK154221C DK 154221 C DK154221 C DK 154221C DK 451981 A DK451981 A DK 451981A DK 451981 A DK451981 A DK 451981A DK 154221 C DK154221 C DK 154221C
Authority
DK
Denmark
Prior art keywords
blood plasma
factor
omega
methyl
pct
Prior art date
Application number
DK451981A
Other languages
Danish (da)
English (en)
Other versions
DK154221B (da
DK451981A (da
Inventor
Lars Gundro Svendsen
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Publication of DK451981A publication Critical patent/DK451981A/da
Publication of DK154221B publication Critical patent/DK154221B/da
Application granted granted Critical
Publication of DK154221C publication Critical patent/DK154221C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10Anilides
    • C12Q2337/12Para-Nitroanilides p-NA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/20Coumarin derivatives
    • C12Q2337/227-Amino-4-methylcoumarin, i.e. AMC, MCA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444Factor X (3.4.21.6)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/802Chromogenic or luminescent peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/28Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/109163Inorganic standards or controls

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
DK451981A 1980-02-12 1981-10-12 Tripeptidderivater og fremgangsmaade til kvantitativt at analysere faktor xa i et xa-holdigt medium, faktor x i blodplasma, heparin i hepariniseret blodplasma eller antifaktor xa i blodplasma DK154221C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH113080 1980-02-12
CH113080 1980-02-12
CH8100014 1981-02-06
PCT/CH1981/000014 WO1981002294A1 (fr) 1980-02-12 1981-02-06 Derives tripeptidiques et leur utilisation pour la determination d'enzymes

Publications (3)

Publication Number Publication Date
DK451981A DK451981A (da) 1981-10-12
DK154221B DK154221B (da) 1988-10-24
DK154221C true DK154221C (da) 1989-05-22

Family

ID=4203192

Family Applications (1)

Application Number Title Priority Date Filing Date
DK451981A DK154221C (da) 1980-02-12 1981-10-12 Tripeptidderivater og fremgangsmaade til kvantitativt at analysere faktor xa i et xa-holdigt medium, faktor x i blodplasma, heparin i hepariniseret blodplasma eller antifaktor xa i blodplasma

Country Status (13)

Country Link
US (2) US4440678A (no)
EP (1) EP0034122B1 (no)
JP (2) JPH032879B2 (no)
AT (1) ATE4702T1 (no)
AU (1) AU581050B2 (no)
CA (1) CA1161432A (no)
DE (1) DE3160903D1 (no)
DK (1) DK154221C (no)
ES (1) ES499343A0 (no)
IL (1) IL62096A (no)
NO (1) NO151787C (no)
WO (1) WO1981002294A1 (no)
ZA (1) ZA81789B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244030A1 (de) * 1982-11-27 1984-05-30 Behringwerke Ag, 3550 Marburg Chromogene verbindungen, verfahren zu ihrer herstellung und ihre verwendung
JPS59112952A (ja) * 1982-12-21 1984-06-29 Taisho Pharmaceut Co Ltd ペプチド誘導体
DE3311287A1 (de) * 1983-03-28 1984-10-04 Behringwerke Ag, 3550 Marburg Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu
EP0128118B1 (de) * 1983-06-03 1991-08-14 Pentapharm A.G. Peptidderivate und deren Verwendung als Substrate zur quantitativen Bestimmung von Enzymen
JPS60241900A (ja) * 1984-05-16 1985-11-30 Nitto Boseki Co Ltd 新規な第Xa因子活性測定用基質
DE3504405A1 (de) * 1985-02-08 1986-08-14 Boehringer Mannheim Gmbh, 6800 Mannheim Bestimmung von prokallikrein
GB8504522D0 (en) * 1985-02-21 1985-03-27 Genetics Int Inc Electrochemistry of mediators
FI860043A (fi) * 1986-01-06 1987-07-07 Orion Yhtymae Oy Peptidsubstrat samt foerfarande foer kvantitativ analys av endotoxin.
SE461494B (sv) * 1986-03-21 1990-02-19 Thorsman & Co Ab Faestanordning foer en elektrisk kopplingsdosa
SE8601327D0 (sv) * 1986-03-21 1986-03-21 Kabivitrum Ab Nya peptidderivat
DE3783966T2 (de) * 1986-07-29 1993-05-27 Sunstar Inc Reagens zur pruefung von periodentalen erkrankungen.
DE3629175A1 (de) * 1986-08-28 1988-03-17 Behringwerke Ag Chromogene verbindungen, verfahren zu deren herstellung und ihre verwendung
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5115099A (en) * 1988-06-14 1992-05-19 Nitto Boseki Co., Ltd. Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates
JPH06104079B2 (ja) * 1988-07-14 1994-12-21 日東紡績株式会社 新規な酵素活性測定用基質
EP0436654A1 (en) 1988-09-30 1991-07-17 The University Of Vermont And State Agricultural College Immunoassays for catalytically-active, serine proteases
US5320945A (en) * 1989-07-14 1994-06-14 Boehringer Mannheim Gmbh Method and reagent for the determination of antithrombin III
CA2039173C (en) * 1989-08-17 1997-04-01 Hendrik C. Hemker Factor ix chromogenic assay
FR2658519B1 (fr) * 1990-02-19 1995-07-07 Serbio Substrats peptidiques pour identification du facteur xa.
US6348570B1 (en) * 1991-08-16 2002-02-19 Merck & Co., Inc. Chromophore containing compounds and their use in determining interleukin-1β convertase activity
US5308756A (en) * 1991-11-20 1994-05-03 Baxter Diagnostics Inc. Protein S chromogenic assay
AU723521B2 (en) * 1996-10-31 2000-08-31 Roche Diagnostics Gmbh Method for the determination of the catalytic activity of factor IXa
US6297024B1 (en) 1998-10-15 2001-10-02 Cell Activation, Inc. Methods for assessing complement activation
US6235494B1 (en) 1999-02-08 2001-05-22 The Scripps Research Institute Substrates for assessing mannan-binding protein-associated serine protease activity and methods using the substrates
WO2000050446A1 (de) * 1999-02-23 2000-08-31 Pentapharm Ag Oligopeptidderivate zur elektrochemischen messung der aktivität von proteasen
WO2003022873A1 (de) * 2001-09-10 2003-03-20 Novel Science International Gmbh Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
DE102005003145B4 (de) * 2005-01-21 2006-10-19 Dade Behring Marburg Gmbh Stablies, chromogenes Flüssigreagenz und dessen Verwendung in gerinnungsdiagnostischen Tests
US8941631B2 (en) 2007-11-16 2015-01-27 Qualcomm Mems Technologies, Inc. Simultaneous light collection and illumination on an active display
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
EP2465941A1 (de) 2010-12-20 2012-06-20 Siemens Healthcare Diagnostics Products GmbH Verfahren zur simultanen Bestimmung mehrerer Gerinnungsproteasen
EP2484775A1 (de) 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
EP2843416A1 (de) 2013-09-02 2015-03-04 Siemens Healthcare Diagnostics Products GmbH Kontroll- und Kalibratormaterial für die Bestimmung von direkten Antikoagulanzien
EP3348649A1 (de) 2017-01-16 2018-07-18 Siemens Healthcare Diagnostics Products GmbH Universales kontrollmaterial für gerinnungsfaktorinhibitor-teste

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE380258B (sv) * 1972-05-02 1975-11-03 Bofors Ab Nya diagnostiskt verksamma substrat med hog specificitet till trypsin och andra enzymer av typen peptidyl-peptid-hydrolaser
US4162941A (en) * 1974-12-05 1979-07-31 Ab Kabi Method for determining a proteolytic enzyme
SE407058B (sv) * 1974-12-05 1979-03-12 Kabi Ab Nya kromogena enzymsubstrat for serinproteaser
CH622286A5 (no) * 1975-06-23 1981-03-31 Pentapharm Ag
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
US4137225A (en) * 1975-07-11 1979-01-30 Ab Kabi Novel chromogenic enzyme substrates
SE407571B (sv) * 1975-07-11 1979-04-02 Kabi Ab Nya kromogena enzymsubstrat for serinproteaser
SE419871B (sv) * 1975-12-01 1981-08-31 Pharmacia Ab Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod
CH634662A5 (de) * 1976-05-28 1983-02-15 Pentapharm Ag Verwendung von tripeptidderivaten zur quantitativen bestimmung von plasminogen-aktivatoren.
SE437153B (sv) * 1976-12-01 1985-02-11 Kabi Ab Specifika kromogena enzymsubstrat for serinproteaser
SE7801373L (sv) * 1978-02-07 1979-08-08 Kabi Ab Lett spjelkbara substrat for kvantifiering av proteaser
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
US4229540A (en) * 1979-07-02 1980-10-21 Cutter Laboratories, Inc. Hydrolase purified from human plasma

Also Published As

Publication number Publication date
DK154221B (da) 1988-10-24
US4440678A (en) 1984-04-03
WO1981002294A1 (fr) 1981-08-20
NO151787B (no) 1985-02-25
EP0034122A1 (de) 1981-08-19
EP0034122B1 (de) 1983-09-21
AU581050B2 (en) 1989-02-09
ES8302780A1 (es) 1983-01-16
DE3160903D1 (en) 1983-10-27
NO813418L (no) 1981-10-09
US4480030A (en) 1984-10-30
ZA81789B (en) 1982-03-31
JPH0253040B2 (no) 1990-11-15
CA1161432A (en) 1984-01-31
ES499343A0 (es) 1983-01-16
DK451981A (da) 1981-10-12
JPS63300A (ja) 1988-01-05
NO151787C (no) 1985-06-05
ATE4702T1 (de) 1983-10-15
AU5220486A (en) 1986-05-15
IL62096A (en) 1986-09-30
IL62096A0 (en) 1981-03-31
JPH032879B2 (no) 1991-01-17
JPS56501849A (no) 1981-12-17

Similar Documents

Publication Publication Date Title
DK154221C (da) Tripeptidderivater og fremgangsmaade til kvantitativt at analysere faktor xa i et xa-holdigt medium, faktor x i blodplasma, heparin i hepariniseret blodplasma eller antifaktor xa i blodplasma
FI77692C (fi) Medel foer paovisning av esterolytiska och/eller proteolytiska enzymer och anvaendningen av detta.
FI931503A (fi) Indolderivat som antiallergiska och antiinflammatoriska aemnen
AR023289A1 (es) COMPUESTOS CON ACTIVIDAD INHIBIDORA DE ENDOPEPTIDASA NEUTRA (NEP), COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y PROCEDIMIENTO PARA SU PREPARACIoN.
IL147596A (en) Test medium and method for identifying and differentiating biological entities
ES2039225T3 (es) Sustratos enzimatizados a base de acridinonas cromogenas.
DE69307131D1 (de) Selektive n-acylation von aminoalkoholen
NO872784D0 (no) Fremgangsmaate til fremstilling av substituerte amino-5,6,7,8-tetrahydronaftyl-oksyeddiksyrer.
YU89791A (sh) Postupak za dobijanje enantioselektivnih derivata fenilizoserina
DE3587981D1 (de) Substrate für Hydrolasen, Verfahren zu ihrer Herstellung und ihre Verwendung.
SE8801702D0 (sv) Sett vid bestemning av enzymatisk aktivitet
DE3577580D1 (de) Mittel und verfahren zum nachweis von redox-systemen.
ES2171964T3 (es) Esteres dibenzodihidropiridinecarboxilicos y su uso en metodos de ensayo quimiluminiscente.
ES2078282T3 (es) Substratos para hidrolasas.
FR2774097B1 (fr) Utilisation de derives d'indolamine dans la detection d'une activite de peptidase ou dans la detection de micro-organismes
ATE319852T1 (de) Neue enzymatische substrate zum nachweis von pseudomonas aeruginosa
KR900013080A (ko) 2-아미노-4-메틸포스피노부티르 산 유도체의 효소에 의한 분할 방법
ATE66217T1 (de) Verfahren zur herstellung von beta(benzthiazolylthio)- und beta(benzimidazolylthio)-carbons|urederivaten.
DE59401952D1 (de) Isatinderivate zum färben von keratinhaltigen fasern
NO975504L (no) Fremgangsmåte for påvisning av forbindelser som modulerer virkningene av fettproteinet
KR860003512A (ko) 백혈구 검출용 조성물
ES8606946A1 (es) Procedimiento para la determinacion cuantitativa de la enzima c1 esterasa.
TR199801683A2 (xx) Yeni �re t�revleri.
ATE271608T1 (de) Inhibitorprotein der dna-gyrase.

Legal Events

Date Code Title Description
PBP Patent lapsed